A randomised Phase II/III study to evaluate the efficacy and safety of orally administered Oxalobacter formigenes to treat primary hyperoxaluria. [electronic resource]
Producer: 20181026Description: 313-323 p. digitalISSN:- 2194-7236
- Adolescent
- Adult
- Biological Therapy -- adverse effects
- Calcium Oxalate -- blood
- Child
- Child, Preschool
- Creatinine -- blood
- Double-Blind Method
- Female
- Glomerular Filtration Rate
- Humans
- Hyperoxaluria, Primary -- blood
- Kidney Calculi -- blood
- Kidney Function Tests
- Male
- Oxalobacter formigenes -- metabolism
- Placebos -- administration & dosage
- Renal Elimination
- Treatment Outcome
- Young Adult
No physical items for this record
Publication Type: Clinical Trial, Phase II; Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.